Glucagon-like peptide-1 (GLP-1 ... But the industry has only scratched the surface of what these drugs can do. A new range of drugs, currently in the research phase, aim to solve bottlenecks from the ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...

Novo has just filed semaglutide, a new glucagon-like peptide (GLP-1) with Japan's regulator for adults with type 2 diabetes. The Copenhagen-headquartered pharma company has also filed the drug ...

An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...